Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases
Clinical trial NCT04083183 · RECRUITING
Trial details
- NCT number
- NCT04083183
- Sponsor
- Fred Hutchinson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-16
- Primary completion
- 2028-01-09
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.